PubMed:32394693
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 18-23 | Body_part | denotes | Heart | http://purl.obolibrary.org/obo/UBERON_0000948 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T1 | 18-23 | Body_part | denotes | Heart | http://purl.org/sig/ont/fma/fma7088 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 166-174 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0000948 | denotes | Heart |
| T2 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0007100 | denotes | Heart |
| T3 | 18-23 | http://purl.obolibrary.org/obo/UBERON_0015228 | denotes | Heart |
| T4 | 18-23 | http://www.ebi.ac.uk/efo/EFO_0000815 | denotes | Heart |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 88-97 | Chemical | denotes | antiviral | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T2 | 102-125 | Chemical | denotes | anti-inflammatory drugs | http://purl.obolibrary.org/obo/CHEBI_35472 |
| T3 | 120-125 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 24-30 | http://purl.obolibrary.org/obo/GO_0048511 | denotes | Rhythm |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-175 | Sentence | denotes | An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2 | 152-160 | Species | denotes | patients | Tax:9606 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 126-148 | Phenotype | denotes | prolonging QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 18-23 | UBERON:0000948 | denotes | Heart |
| T2 | 53-60 | UBERON:0000948 | denotes | Cardiac |
| T3 | 88-97 | CHEBI:33282;CHEBI:33282 | denotes | antiviral |
| T4 | 102-125 | CHEBI:35472;CHEBI:35472 | denotes | anti-inflammatory drugs |
| T5 | 166-174 | SP_7 | denotes | COVID-19 |
Inflammaging
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-175 | Sentence | denotes | An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19. |
| T1 | 0-175 | Sentence | denotes | An opinion of the Heart Rhythm Section of the Polish Cardiac Society on safety of using antiviral and anti-inflammatory drugs prolonging QT interval in patients with COVID-19. |